跳至主要内容
临床试验/CTRI/2010/091/003048
CTRI/2010/091/003048已完成未知

MTB complex Interferon Gamma Release Assay (IGRA) in blood and CSF of Tuberculous meningitis patients

I0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Fever, headache, meningismus, other signs and clinical presentations of meningitis of more than 2 weeks duration.
  • 2.Typical cerebrospinal fluid (CSF) features including pleocytosis with more than 20 cells, lymphocytes greater than 60%, protein greater than 100mg% and glucose level less than 60% of the corresponding blood glucose level.
  • Presumptive diagnosis of TBM will be made based on the clinical criteria with typical CSF features and at least one of the following supporting criteria:
  • 1.Radiographic findings based on chest X-ray that confirmed pulmonary TB (reticulonodular pattern in upper lobes with or without cavitatory lesions),
  • 2. Hydrocephalous from brain computerized tomography (CT) scan,
  • 3.Response to anti-tuberculous treatment after 4 weeks.

排除标准

  • 1.The patients who already received more than 30 days of antituberculous drugs and steroids.
  • 2.The patient declined to give consent.

研究者

发起方
I

相似试验